ivWatch Presents Miniaturized Biosensor Technology at the Synova NICU Leadership Forum and Infusion Nurses Society 2023 Conferences

Newport News, VA, March 7, 2023– ivWatch, LLC actively showcases the only continuous IV site monitoring technology this Spring in a tradeshow circuit. ivWatch has spent 20 years in research and development to design an optical sensor  that notifies clinicians of peripheral IV infiltration and extravasation events early, before physical signs or symptoms are present.

The upcoming spring event schedule is bigger than previous years, with numerous events on the horizon. ivWatch will exhibit at this year’s Synova NICU Leadership Forum in Tucson, Arizona from March 19 -23, 2023, to meet with clinicians and give in-person demonstrations of the SmartTouch miniaturized sensor. The system is FDA cleared and globally trusted on patients of all ages and sizes. Clinical leaders can meet ivWatch experts at booth 403 to see how the technology can help protect even the smallest of patients.

ivWatch will also exhibit at the 2023 Infusion Nurses Society’s annual event on April 1-4, 2023, celebrating 50 years of excellence. Clinicians can stop by booth 47 to see the ivWatch team and learn more about how continuous monitoring can aide in the current standard of care, and to add a second set of eyes on patient’s IV sites. Early IV infiltration detection can improve patient safety and patient outcomes.  

Make sure to continue checking on ivWatch’s site for more information about upcoming events.

About ivWatch, LLC
ivWatch, LLC  is a biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians can leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative IV site monitoring solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch, Facebook @ivWatchLLC, and LinkedIn @ivWatch-LLC, or visit  www.ivWatch.com.

MEDIA CONTACT:
Erin Wendell
erin.wendell@ivwatch.com
Mobile (410) 952-3800